[What are the differences between well-being therapy and anxiety management in the school setting?].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 21268411)

Published in Riv Psichiatr on January 26, 2011

Authors

Carlotta Belaise1, Elena Tomba, Emanuela Offidani, Dalila Visani, Fedra Ottolini, Alessandra Bravi, Elisa Albieri, Chiara Ruini, Chiara Rafanelli, Ernesto Caffo, Giovanni A Fava

Author Affiliations

1: Dipartimento di Psicologia, Università di Bologna. carlottabelaise@libero.it

Articles by these authors

Psychometric theory is an obstacle to the progress of clinical research. Psychother Psychosom (2004) 3.04

Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry (2004) 2.68

Long-term treatment with antidepressant drugs: the spectacular achievements of propaganda. Psychother Psychosom (2002) 2.11

Clinical assessment of allostatic load and clinimetric criteria. Psychother Psychosom (2010) 2.08

Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis. Psychother Psychosom (2013) 1.73

The biopsychosocial model thirty years later. Psychother Psychosom (2007) 1.68

Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom (2004) 1.51

Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review. Psychother Psychosom (2013) 1.50

Mood and anxiety disorders as early manifestations of medical illness: a systematic review. Psychother Psychosom (2014) 1.46

Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach. CNS Drugs (2003) 1.44

Well-being therapy of generalized anxiety disorder. Psychother Psychosom (2005) 1.44

Is depression the wrong treatment target for improving outcome in coronary artery disease? Psychother Psychosom (2013) 1.43

Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia. Int J Neuropsychopharmacol (2007) 1.39

Unmasking special interest groups: the key to addressing conflicts of interest in medicine. Psychother Psychosom (2010) 1.38

The biopsychosocial factor. Psychother Psychosom (2011) 1.38

Increasing psychological well-being and resilience by psychotherapeutic methods. J Pers (2009) 1.34

The concept of recovery in major depression. Psychol Med (2007) 1.27

Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychother Psychosom (2015) 1.16

The cult of mediocrity. Psychother Psychosom (2005) 1.15

Stressful life events, depression and demoralization as risk factors for acute coronary heart disease. Psychother Psychosom (2005) 1.04

Assessing demoralization and depression in the setting of medical disease. J Clin Psychiatry (2005) 1.03

Development and characteristics of a well-being enhancing psychotherapeutic strategy: well-being therapy. J Behav Ther Exp Psychiatry (2003) 1.01

Staging of mental disorders: systematic review. Psychother Psychosom (2012) 0.98

Well-being therapy in school settings: a pilot study. Psychother Psychosom (2006) 0.97

The road to recovery from depression--don't drive today with yesterday's map. Psychother Psychosom (2007) 0.97

New modalities of assessment and treatment planning in depression: the sequential approach. CNS Drugs (2010) 0.97

Role of well-being therapy in achieving a balanced and individualized path to optimal functioning. Clin Psychol Psychother (2012) 0.97

The clinical process in psychiatry: a clinimetric approach. J Clin Psychiatry (2011) 0.95

Factors associated with dropout from treatment for eating disorders: a comprehensive literature review. BMC Psychiatry (2009) 0.95

The mechanisms of tolerance in antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.95

Agoraphobia: a review of the diagnostic classificatory position and criteria. Depress Anxiety (2010) 0.94

Mania associated with venlafaxine discontinuation. Int J Neuropsychopharmacol (2003) 0.94

Psychosomatic aspects of Cushing's syndrome. Rev Endocr Metab Disord (2010) 0.93

[Long-term treatment of depression: there is more than drugs]. Recenti Prog Med (2002) 0.93

School intervention for promoting psychological well-being in adolescence. J Behav Ther Exp Psychiatry (2009) 0.91

Well-being therapy for generalized anxiety disorder. J Clin Psychol (2009) 0.91

Sequential treatment of mood and anxiety disorders. J Clin Psychiatry (2005) 0.91

Psychosocial impairment in patients treated for pituitary disease: a controlled study. Clin Endocrinol (Oxf) (2007) 0.91

The Illness Attitude Scales. A clinimetric index for assessing hypochondriacal fears and beliefs. Psychother Psychosom (2008) 0.90

Information overload, the patient and the clinician. Psychother Psychosom (2007) 0.90

The sequential combination of cognitive behavioral treatment and well-being therapy in cyclothymic disorder. Psychother Psychosom (2011) 0.89

Innovative trends in the design of therapeutic trials in psychopharmacology and psychotherapy. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.89

The relationship of psychological well-being to distress and personality. Psychother Psychosom (2003) 0.88

New strategies in the assessment of psychological factors affecting medical conditions. J Pers Assess (2007) 0.88

A different medicine is possible. Psychother Psychosom (2006) 0.87

[New drugs of abuse on the Web: the role of the Psychonaut Web Mapping Project]. Riv Psichiatr (2010) 0.87

The unifying concept of illness behavior. Psychother Psychosom (2012) 0.86

Psychosomatic assessment of skin diseases in clinical practice. Psychother Psychosom (2005) 0.85

The clinical inadequacy of evidence-based medicine and the need for a conceptual framework based on clinical judgment. Psychother Psychosom (2014) 0.84

Psychosomatic characterization of adjustment disorders in the medical setting: some suggestions for DSM-V. J Affect Disord (2006) 0.84

Circadian blood pressure patterns and life stress. Psychother Psychosom (2002) 0.84

Psychological aspects of primary aldosteronism. Psychother Psychosom (2006) 0.84

Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. J Affect Disord (2012) 0.83

Cognitive behavior approach to loss of clinical effect during long-term antidepressant treatment: a pilot study. Am J Psychiatry (2002) 0.83

Issues for DSM-V: psychological factors affecting either identified or feared medical conditions: a solution for somatoform disorders. Am J Psychiatry (2007) 0.83

Subtyping depression in the medically ill by cluster analysis. J Affect Disord (2011) 0.83

Criteria for psychosomatic research (DCPR) in the medical setting. Curr Psychiatry Rep (2010) 0.82

Personality characteristics and quality of life in patients treated for Cushing's syndrome. Clin Endocrinol (Oxf) (2006) 0.81

Psychological assessment of primary aldosteronism: a controlled study. J Clin Endocrinol Metab (2011) 0.81

Agoraphobia is a disease: a tribute to Sir Martin Roth. Psychother Psychosom (2008) 0.81

Treatment selection in depression: the role of clinical judgment. Psychiatr Clin North Am (2012) 0.81

How citation analysis can monitor the progress of research in clinical medicine. Psychother Psychosom (2004) 0.81

Protective environments and health status: cross-talk between human and animal studies. Neurobiol Aging (2005) 0.81

Psychological assessment in cardiac rehabilitation. Psychother Psychosom (2003) 0.81

Well-being therapy in children with emotional and behavioral disturbances: a pilot investigation. Psychother Psychosom (2009) 0.81